Skip to main content
. 2012 Oct 20;2(3):160–169.

Table 1.

Involvement of oncogenes and gatekeeper tumor suppressor genes in genetic instability.

Oncogene or Tumor suppressor gene Involvement in tumors Type of genetic instability associated with dysfunction Putative mechanism for genetic instability
myc Overexpression (amplification, translocation, or most often, indirect) s-CIN Overreplication (S phase stimulation)
ras Mutation altering the aminoacid sequence Overexpression s-CIN w-CIN? Overreplication Control myc activity? Centrosome amplification through cyclin D1
Cyclin D1 Overexpression (amplification, translocation, or most often, indirect) s-CIN w-CIN? Overreplication (S phase stimulation) Centrosome amplification
Cyclin E Overexpression (amplification, or most often, indirect) s-CIN Impairment of S phase progression Forcing premature S phase entry under conditions of nucleotide deficiency
p53 mutant and p53 wild-type Mutation altering the aminoacid sequence + overexpression Lack of expression s-CIN, w-CIN Overreplication (control of myc ?) Loss of mitotic checkpoint Centrosome amplification Tolerance to aneuploidy
APC Lack of expression (most often) s-CIN? w-CIN Control of myc through b-catenin Role in chromosome segregation
Rb Lack of expression (gene inactivation, or most often, indirect) w-CIN s-CIN? Forcing premature S phase entry under conditions of nucleotide deficiency Centrosome amplification
?

is used when the corresponding type of genetic instability, although predictable, has not been clearly demonstrated